Alexander Cubberley
Cardiovascular Disease · Golden, CONPI 1386174621
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.4%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Medtronic at 38.9% of the total. Among cardiovascular disease clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $113.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Abbott$9K
- Boston Scientific$2K
- Impulse Dynamics (USA) Inc.$442
- Abiomed$369
- Johnson & Johnson$327
- plus $2K from 19 others
What the payments were for
- Grants$2,0009%
- Travel & lodging$8,55637%
- Food & beverage$11,51650%
- Education$7663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 79 | $8,881 |
| Abbott | 78 | $8,585 |
| Boston Scientific | 9 | $2,309 |
| Impulse Dynamics (USA) Inc. | 3 | $442 |
| Abiomed | 3 | $369 |
| Johnson & Johnson | 4 | $327 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $212 |
| AstraZeneca | 2 | $189 |
| Corindus Inc. | 1 | $149 |
| Shockwave Medical, Inc | 1 | $125 |
| Teleflex LLC | 1 | $125 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| AbbVie | 1 | $124 |
| Novo Nordisk | 2 | $123 |
| Philips North America LLC | 1 | $118 |
| Pfizer | 1 | $114 |
| Amarin Pharma, Inc. | 1 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $95 |
| Amgen | 1 | $80 |
| Novartis | 3 | $71 |
| Edwards Lifesciences | 1 | $55 |
| Scpharmaceuticals Inc. | 3 | $49 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Biosense Webster, Inc. | 1 | $23 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$4,182
- OPTIMIZER$885
- AVEIR$833
- ENSITE$551
- Micra$313
- XARELTO$310
- Impella$278
- ARCTIC FRONT ADVANCE$259
- AURORA EV-ICD MRI SURESCAN$158
- CorPath GRX$149
- WATCHMAN Access System$142
- CARDIOMEMS$140
- AZURE XT DR MRI SURESCAN$138
- XIENCE SKYPOINT$138
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$128
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$125
- MANTA$125
- NEXLIZET$125
- NEXLETOL$125
- Mavyret$124
How this compares
$22,839 in reported general payments places this provider in the 90th percentile of 276 cardiovascular disease providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $28,531 |
| ClopidogrelClopidogrel Bisulfate | 30 | $224 |
| Metoprolol Succinate | 13 | $146 |
| Pantoprazole Sodium | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $114 | $28,53135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 276 cardiovascular disease providers in Colorado.
Other cardiovascular disease in Golden
- Payal KohliAurora$1.7M
- Marc BonacaAurora$703K
- Andrew FreemanDenver$454K
- William SauerAurora$365K
- Jeffrey BooneGreenwood Village$287K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Deborah JalowiecColorado Springs$106K
- Edward GillAurora$96K
- Sameer MehtaDenver$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.